#National Cancer Institute

Launched by Total Health, the nonprofit Cancer Equity Project addresses patients and clinicians in marginalized communities.

American Cancer Society and ACS Cancer Action Network strongly support Monica M. Bertagnolli, MD, as the next NIH director.

The drug, revumenib, is a menin inhibitor that has led to remission in clinical trials involving acute myeloid leukemia.

Accelerated progress is needed to achieve Cancer Moonshot goal of cutting the age-adjusted cancer death rate by at least 50% over 25 years.

The American Cancer Society and ACS CAN applaud the pick. Bertagnolli, an oncologist, has been running the National Cancer Institute.

In this Q&A, National Cancer Institute Director and Deputy Director for Clinical and Translational Research talk about clinical trials

New researcher shows how unnatural disasters linked to climate change can increase the risk of cancer and affect cancer care.

Here’s how the American Cancer Society and its advocacy affiliate support eight priorities of the National Cancer Plan.

The National Cancer Plan offers a road map for collaboration across cancer programs and bolsters the goals of the Cancer Moonshot.

Some childhood cancer survivors develop heart problems later in life, due in part to the chemo that helped save them. Zinecard can help.

For some patients, it may be adequate to remove only the section of a lung lobe that contains a tumor.

“We must work to ensure individuals aren’t forced to choose between their treatment and their employment,” says ACS CAN’s president.

Immunotherapy and … nothing else? Studies test a potential paradigm shift in treatment for some people with early stage cancers.

A study finds that Black and Latino patients with cancer nearing the end of life are less likely than white patients to get needed opioids.

This treatment represents a “fairly substantial breakthrough” for patients with HER2-positive advanced colorectal cancer.

A team of experts on acute promyelocytic leukemia (APL) were available by phone or email to other oncologists treating this rare cancer.